NWK Group’s NeoGenomics NEO Stock Holding History

NWK Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-750	Closed	-$36K	–	138
2021 Q1	$36K	Hold	750	–	–	0.02%	122
2020 Q4	$40K	Hold	750	–	–	0.02%	116
2020 Q3	$28K	Hold	750	–	–	0.01%	119
2020 Q2	$23K	Buy	+750	New	+$20.8K	0.01%	122

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

NWK Group's NEO Position: Q2 2021 in Review

NWK Group sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 750 shares — an estimated $36K sold.

NWK Group first reported a position in NEO in Q2 2020 and held it in 4 quarters. The position peaked at $40K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

NWK Group reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
NWK Group sold 750 NeoGenomics shares in Q2 2021, an estimated $36K.
NWK Group first reported a position in NeoGenomics in Q2 2020 and held it in 4 quarters.
NWK Group's NeoGenomics position peaked at $40K in Q4 2020.
311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on NWK Group's 13F filing for Q2 2021, filed 16 Aug 2021.